Filter
73
Filtered Results: 73
Text search:
Ramanathan,
K.
Featured
Recommendations
10
New Publications
17
Language
Document type
Studies & Reports
30
No document type
25
Guidelines
13
Manuals
3
Training Material
1
Strategic & Response Plan
1
Countries / Regions
Global
7
India
6
Brazil
4
Mozambique
2
Guinea-Bissau
2
Angola
2
Nepal
1
Kenya
1
Burkina Faso
1
USA
1
Asia
1
Latin America and the Carribbean
1
Russia
1
Botswana
1
Indonesia
1
Authors & Publishers
Publication Years
Category
COVID-19
4
Studies & Reports
4
Guidelines
3
Capacity Building
3
Communicable Diseases
2
Drugs & Medical Equipment
2
Disabilities
2
TB
2
Paediatrics
1
Infection Control & Prevention (IPC)
1
Clinical Guidelines
1
Policies & Guidelines HIV & TB
1
Women & Child Health
1
Community Health
1
Immunization
1
General Guidelines
1
Primary Health Care
1
Parasitology
1
Non-communicable Diseases
1
Neonatal Care
1
Toolboxes
Clinical Guidelines
8
Prevention & Control
3
Children & Adolescents
3
Essential Medicines & Medical Devices
3
Planetary Health
3
Essential Medicines & Devices Lists
3
Mental Health
3
Health Impact & Climate Change
3
Health Financing Toolbox
3
Childhood TB
2
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
2
Children/Adolescents Mental Disorders
2
Cannabis
2
Country specific documents
2
Hospital Readiness/Essential Health Services
2
Climate Change General
2
General Information & Methodology
2
Drugs
1
Policies & Strategies
1
General Reports
1
Country specific
1
Adults
1
Pediatrics
1
Policies & Programmes
1
Curricula & Core Competencies
1
Laboratory
1
Studies & Reports
1
Human Rights
1
Epilepsy
1
Reports
1
IEC Substance Use Disorders
1
Communication & Training
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Health Personnel
1
Infection Prevention & Hygiene
1
Global Impact: Socio-economic, health services, TB & HIV
1
TB/HIV
1
Hygiene
1
Ethics
1
Midwives
1
Nurses
1
Overview
1
Brazil
1
Clean air
1
Pediatrics
1
Guiding documents and principles
1
Land-system change
1
Biogeochemical flows
1
Epilepsy
1
Prevention & Measures
1
Antimicrobial Resistance (AMR)
1
Others
1
Ethics
1
Health Care In Conflict Settings
1
Detection & Diagnosis
1
Asia and Pacific
1
Drug resistant TB
1
Substance Use Disorders & Addiction
1
General Aspects
1
Disease Prevention & Control
1
Training
1
Research & Access
1
Assessment
1
HIV and coinfection
1
TB/HIV Coinfection
1
Clinical Guidelines
1
HIV service delivery
1
TB
1
Unaccompanied Refugee Minors
1
Reports & Studies
1
SEAR (South-east Asia Region)
1
This manual presents a compelling case for action on carbapenem-resistant organisms (CROs) and describes the linkages between the prevention and control of CROs and the Global Action Plan on Antimicrobial Resistance (AMR). It describes how the eight recommendations contained within the World Health ...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...
Update, 23 de junio de 2022
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Mental disorders are a leading cause of the global burden of disease, and the provision of mental health services in developing countries remains very limited and far from equitable. Using the Creditor Reporting System, we estimate the amounts and patterns of development assistance for global mental...
Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health
(RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and
the Organisation for Economic Co-operation and Development (OECD) policy marker. We...
Little is known about the patterns of development assistance (DA) for each component of reproductive, maternal, newborn, child and adolescent health (RMNCAH) in conflict-affected countries nor about the DA allocation in relation to the burden of disease
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
